Other

Coronavirus boosts sales for French pharma giant Sanofi

French pharmaceutical giant Sanofi said Friday that its first quarter sales surged in part due to stockpiling of the painkiller Doliprane, as other companies around the world struggle during the coronavirus pandemic.

Other

Novartis to buy back $5 bn in shares

Swiss pharmaceutical giant Novartis announced Wednesday a $5.0 billion share buyback even though competition from generics ate away at sales and earnings last year.

Other

GSK sees earnings rise amid good demand for vaccines

Pharmaceutical company GlaxoSmithKline says its net profit rose 50 percent in the third quarter to 808 million pounds ($986 million) thanks in part to strong sales of its vaccine products.

Medications

Novartis profit slips as generic drug competition hits sales

Swiss pharmaceuticals company Novartis says its net profit fell 4 percent in the second quarter, largely because of new generic competition for its top cancer drug, though it expressed high hopes for a psoriasis drug that ...

Medications

Novartis profits dip as generic rival challenges cancer drug

Swiss pharmaceuticals maker Novartis says net income from continued operations fell 13 percent in the first quarter as generic competition cut into sales of Gleevec, one of the first very effective cancer medicines.

page 1 from 3